Invention Grant
US08969336B2 Diamino heterocyclic carboxamide compound 有权
二氨基杂环羧酰胺化合物

Diamino heterocyclic carboxamide compound
Abstract:
Provided is a compound useful as an inhibitor against the kinase activity of EML4-ALK fusion protein.As a result of intensive and extensive studies on compounds having inhibitory activity against the kinase activity of EML4-ALK fusion protein, the present inventors found that the diamino heterocyclic carboxamide compounds of the present invention had inhibitory activity against the kinase activity of EML4-ALK fusion protein. By this finding, the present invention was completed. The compounds of the present invention can be used as a pharmaceutical composition for preventing and/or treating cancer, such as lung cancer, non-small cell lung cancer, and small cell lung cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0